While CD39 and COX-2 were co-expressed in circulating CD4+ T cells of HNSCC patients, IL-10 and TGF-β were expressed by a non-overlapping, distinct subset of CD4+ T cells. This evidence concerns the gene TGFB1 and head and neck squamous cell carcinoma.